Evonik Rexim (Nanning) Pharm. Co. v. United States
Opinion
*1365
This consolidated action involving a remand determination was brought by Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and Evonik Corporation (collectively, "Evonik" or "Plaintiffs"), Baoding Mantong Fine Chemistry Co., Ltd. ("Baoding"), and GEO Specialty Chemicals, Inc. ("GEO") (collectively, "Consolidated Plaintiffs") for judicial review of decisions made by the U.S. Department of Commerce ("Commerce" or "Department") during the 2013-2014 administrative review of the antidumping duty order on glycine from the People's Republic of China ("China" or "PRC").
See
Glycine From the People's Republic of China
,
BACKGROUND
Commerce issued the Final Results and accompanying memorandum on October 15, 2015.
See
Final Results
,
Plaintiffs and Consolidated Plaintiffs initiated multiple actions challenging Commerce's determination. The court sustained Commerce's determinations that (1) Evonik's sales during the period of review were not
bona fide
, (2) Baoding's sale was
bona fide
, and (3) Baoding should receive a by-product offset.
Evonik
, 41 CIT at ----,
*1366
The Department filed the final Remand Results on October 20, 2017. See Remand Results. Commerce followed the court's instructions, accepted Baoding's administrative case brief, and provided GEO with an opportunity to respond. See id. at 1. After considering both parties' arguments, Commerce determined that the Global Trade Atlas ("GTA") import data for anhydrous ammonia was the most product-specific data placed on the record for the period of review for Baoding's liquid ammonia input. See id. at 12. The Department determined also that PT Budi's financial information should be used to generate surrogate financial ratios for Baoding because the Indonesian company produced merchandise comparable to glycine. See id. at 15. Pursuant to its modified calculations, the Department assigned Baoding a weighted-average dumping margin of zero percent. See id. at 21-22. Baoding filed a comment in support of the Remand Results. See Consolidated Pl.'s Comments Final Remand Results, Nov. 20, 2017, ECF No. 87. GEO challenges the Remand Results, contending that Commerce's two findings are not supported by substantial evidence and not in accordance with law. See Def.-Intervenor's Comments Final Results Redetermination Pursuant Ct. Remand 8, Nov. 20, 2017, ECF No. 85 ("GEO Comments"). Defendant responded to both comments. See Def.'s Corrected Resp. Comments Remand Redetermination, Dec. 18, 2017, ECF No. 92.
JURISDICTION
The court has jurisdiction over Commerce's final determination in an administrative review of an antidumping duty order.
See
DISCUSSION
When conducting an antidumping duty investigation involving a non-market economy ("NME"), if Commerce determines that available information does not permit the use of the standard normal value calculation, then the Department will calculate normal value using the best available information from "a market economy country or countries considered to be appropriate by" the agency. 19 U.S.C. § 1677b(c)(1)(B). Commerce will examine "the value of the factors of production utilized in producing the merchandise" plus "the cost of containers, coverings, and other expenses."
When valuing the factors of production, the Department "normally will use non-proprietary information gathered from producers of identical or comparable merchandise in the surrogate country."
I. Commerce's Switch to the Anhydrous Ammonia Surrogate Value
Commerce originally selected the surrogate value for aqueous ammonia to calculate Baoding's normal value.
Evonik
, 41 CIT at ----,
GEO asserts that Commerce's switch from selecting aqueous ammonia to anhydrous ammonia for the surrogate value is not supported by the record evidence and not in accordance with law.
See
GEO Comments 8-9. GEO argues that Commerce reversed its position on remand despite the fact that "the record evidence on the liquid ammonia surrogate value issue did not change; all that changed was Commerce's reinstatement of the original briefs filed by Baoding and GEO providing legal arguments addressing this issue."
Id.
at 9. The presence of additional briefing at the administrative level was significant, however, because the Department had more information and arguments to consider in making its decision. The Department is allowed to "change its conclusions from one review to the next based on new information and arguments, as long as it does not act arbitrarily and it articulates a reasonable basis for the change."
Qingdao Sea-Line Trading Co., Ltd.
,
GEO contends further that the Department relied incorrectly on findings from the 2005/2006, 2006/2007, and 2007/2008 administrative reviews, which were unverified, and should have used information instead from the 2003/2004 and 2010/2011 reviews, "which were the only two reviews where Commerce verified" Baoding's factors-of-production information.
See
GEO Comments 11-12. GEO asserts that deference should be given to verified findings.
See
id.
at 12-13 (citing
Timken U.S. Corp. v. United States
,
II. Commerce's Finding on Surrogate Financial Ratios
The Department utilizes a three-part test when determining surrogate financial ratios, which requires it to compare the physical characteristics, end uses, and production processes for the respondent's and surrogate company's goods.
See
Remand Results 14. The court concluded previously that "the Department failed to adequately support its determination that PT Budi and PT Lautan engaged in production processes comparable to Baoding's glycine production."
Evonik
, 41 CIT at ----,
GEO asserts that the Department rejected PT Lautan's financial statement correctly, but disagrees with the Department's determination that PT Budi satisfied the three-part test. See GEO Comments 13-14. Defendant-Intervenor contends that PT Budi and Baoding do not share similar production processes because there are no chemical *1369 reactions required for manufacturing PT Budi's "primary product, tapioca starch." 3 See GEO Comments 17. GEO requests that the court remand this issue and direct the Department to consider data from the companies that GEO placed on the record for surrogate financial ratios. See id. at 17-18. GEO's focus, however, is misplaced. Although PT Budi does produce tapioca starch, thirty-two percent of its revenue is derived from the manufacture and sale of sweeteners. See Financial Statements: PT Budi Starch and Sweetener Tbk at 34-35, Exhibit 7 of Evonik Surrogate Value Comments, PD 98-99, bar code 3229327-02 (Sept. 19, 2014). The Department cited to information regarding PT Budi's manufacturing process for sweeteners, along with Baoding's glycine manufacturing process. See Remand Results 14-17. The Department found, after examining these documents, that Baoding and PT Budi share similar production processes because they both "involve chemical reactions and heating, cooling and drying processes." Id. at 15. Based on the information in the record, the court concludes that this determination was supported by substantial evidence and in accordance with law.
CONCLUSION
For the reasons set forth above, the court finds that Commerce has complied with the court's previous opinion and remand order by (1) considering Baoding's administrative brief in selecting the surrogate value for liquid ammonia, and (2) providing its reasoning with respect to the issue of financial surrogate ratios. The court concludes that Commerce's choice to utilize anhydrous ammonia for the surrogate value, as well as its selection of PT Budi as the surrogate company for determining the financial surrogate ratio, were supported by substantial evidence and in accordance with law. The court sustains Commerce's remand redetermination.
Judgment will be issued accordingly.
Further citations to Title 28 of the U.S. Code are to the 2012 edition.
Further citations to the Tariff Act of 1930, as amended, are to the relevant provisions of Title 19 of the U.S. Code, 2012 edition.
GEO also disputes that PT Budi's products do not have similar physical characteristics or comparable end uses to Baoding's products. See GEO Comments 14-17. The Department found that PT Budi "produce[s] basic chemicals and additives to be used in food and pharmaceutical products, as does Baoding Mantong with its production of glycine," Remand Results 14, and determined that "the physical characteristics ( i.e. , a chemical powder with sweetening properties) of the products produced by the two companies and the end uses of the products are virtually identical." Id. at 20. The court did not take issue with these two prongs of the Department's three-part test in its prior opinion, but nevertheless concludes that the Department's determinations are satisfactory.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.